Camila Castillo Ferrer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Camila Castillo Ferrer has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Amandine Hurbin
Institute for Advanced Biosciences, Institut National de la Santé Et de la Recherche Médicale INSERM U1209, Centre National de la Recherche Scientifique CNRS UMR5309, Université Grenoble Alpes, F-38000 Grenoble, France
1 shared publication - Anne-Sophie Gauchez
CHU Grenoble
1 shared publication - Florent Chuffart
Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences
1 shared publication - Gabriel Ichim
Cancer Research Center of Lyon (CRCL) INSERM 1052, CNRS 5286, Lyon, France; LabEx DEVweCAN, Universite de Lyon, Lyon, France
1 shared publication - Jean-Luc Coll
Institute for Advanced Bioscience
1 shared publication - Julie Charles
CHU de Grenoble, 38700 Grenoble, France
1 shared publication
Latest Publications
- 12 August 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (2) , 422-426.e8
Serum IGF1 Is a Prognostic Marker for Resistance to Targeted Therapies and a Predictive Marker for Anti-IGF1 Receptor Therapy in Melanoma
- 12 August 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (2) , 422-426.e8
Serum IGF1 Is a Prognostic Marker for Resistance to Targeted Therapies and a Predictive Marker for Anti-IGF1 Receptor Therapy in Melanoma
- Open Access
- 11 November 2020
- Published by Wiley in The FEBS Journal
- Vol. 288 (15) , 4445-4463
Apoptosis – Fueling the oncogenic fire
Apoptosis, the most extensively studied form of programmed cell death, is essential for organismal homeostasis. Apoptotic cell death has widely been reported as a tumor suppressor mechanism. However, recent studies have shown that apoptosis exerts noncanonical functions and may paradoxically promote tumor growth and metastasis. The hijacking of apoptosis by cancer cells may arise at different levels, either via the interaction of apoptotic cells with their local or distant microenvironment, or through the abnormal pro‐oncogenic roles of the main apoptosis effectors, namely caspases and mitochondria, particularly upon failed apoptosis. In this review, we highlight some of the recently described mechanisms by which apoptosis and these effectors may promote cancer aggressiveness. We believe that a better understanding of the noncanonical roles of apoptosis may be crucial for developing more efficient cancer therapies.
- 11 November 2020
- Published by Wiley in The FEBS Journal
- Vol. 288 (15) , 4445-4463
Open AccessApoptosis – Fueling the oncogenic fire
Apoptosis, the most extensively studied form of programmed cell death, is essential for organismal homeostasis. Apoptotic cell death has widely been reported as a tumor suppressor mechanism. However, recent studies have shown that apoptosis exerts noncanonical functions and may paradoxically promote tumor growth and metastasis. The hijacking of apoptosis by cancer cells may arise at different levels, either via the interaction of apoptotic cells with their local or distant microenvironment, or through the abnormal pro‐oncogenic roles of the main apoptosis effectors, namely caspases and mitochondria, particularly upon failed apoptosis. In this review, we highlight some of the recently described mechanisms by which apoptosis and these effectors may promote cancer aggressiveness. We believe that a better understanding of the noncanonical roles of apoptosis may be crucial for developing more efficient cancer therapies.